01 1Jiangsu Tianhe Pharmaceutical Co., Ltd.
02 1Sterling Pharma Solutions Limited
03 1Zenfold Sustainable Technologies Private Limited
04 1Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
01 1GRAPIPRANT
02 3Grapiprant
01 2China
02 1India
03 1United Kingdom
NDC Package Code : 50384-0500
Start Marketing Date : 2015-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69169-128
Start Marketing Date : 2024-07-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 83886-003
Start Marketing Date : 2024-10-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 12666-0022
Start Marketing Date : 2023-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Grapiprant manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Grapiprant, including repackagers and relabelers. The FDA regulates Grapiprant manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Grapiprant API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Grapiprant manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Grapiprant supplier is an individual or a company that provides Grapiprant active pharmaceutical ingredient (API) or Grapiprant finished formulations upon request. The Grapiprant suppliers may include Grapiprant API manufacturers, exporters, distributors and traders.
click here to find a list of Grapiprant suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Grapiprant as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Grapiprant API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Grapiprant as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Grapiprant and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Grapiprant NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Grapiprant suppliers with NDC on PharmaCompass.
We have 4 companies offering Grapiprant
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
